Publication

Alternative PET tracers in head and neck cancer. A review

Wedman, J., Pruim, J., Roodenburg, J. L. N., Halmos, G., Langedijk, J. A., Dierckx, R. A. J. O. & van der Laan, B. F. A. M., Sep-2013, In : European Archives of Oto-Rhino-Laryngology. 270, 10, p. 2595-2601 7 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Positron emission tomography (PET) has become a standard in staging Head and Neck cancer. While F-18-fluoro-2-deoxy-d-glucose (FDG) is the most frequently used radiopharmaceutical, glycolysis is not the only metabolic process that can be visualized. Different PET tracers can also be used to visualize other metabolic processes and in this manner, the disadvantages of FDG PET can be avoided. In this review, we describe a comprehensive overview of alternatives to FDG that can be used in identifying head and neck cancer. The potential advantages and disadvantages of these radiopharmaceuticals are discussed.

Original languageEnglish
Pages (from-to)2595-2601
Number of pages7
JournalEuropean Archives of Oto-Rhino-Laryngology
Volume270
Issue number10
Publication statusPublished - Sep-2013

    Keywords

  • PET, Amino acids, Nucleoside, Hypoxia, Monoclonal antibodies, POSITRON-EMISSION-TOMOGRAPHY, SQUAMOUS-CELL CARCINOMA, PROTEIN-SYNTHESIS RATE, TUMOR HYPOXIA, EARLY RESPONSE, F-18-FDG PET, MONOCLONAL-ANTIBODIES, LARYNGEAL CARCINOMAS, KINETIC-ANALYSIS, C-11 METHIONINE

ID: 5943746